Search research articles
Contact Us
Filters
Showing results (31-40 of 257) with videos related to
Page
of 26
Sort By:
Expert Review of Cardiovascular Therapy
|
August 4, 2005
Ximelagatran for stroke prevention in atrial fibrillation
Christopher J Boos, Gregory Y H Lip
Klinische Padiatrie
|
July 1, 1996
[HIT-GBM: multicenter study of treatment of children with malignant glioma]
J E Wolff, J Boos, J Kühl
Journal of the American College of Cardiology
|
February 21, 2006
Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers
Christopher J Boos, Gregory Y H Lip
Heart (British Cardiac Society)
|
September 15, 2005
Antithrombotic treatment in atrial fibrillation
G Y H Lip, C J Boos
Journal of Human Hypertension
|
May 21, 2005
Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension?
C J Boos, G Y H Lip
American Journal of Hypertension
|
May 2, 2006
Urotensin and cardiovascular risk among patients with end-stage renal disease: fact or fiction?
Christopher J Boos, Gregory Y H Lip
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
July 15, 2004
Multiple tumors associated with late-onset congenital adrenal hyperplasia due to aberrant splicing of adrenal 21-hydroxylase gene
Chris J Boos, Gill Rumsby, Glenn Matfin
Expert Opinion on Investigational Drugs
|
November 30, 2004
Novel therapies for the prevention of stroke
Christopher J Boos, Gregory Y H Lip
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 21, 2006
Assessment of hemostatic risk factors in predicting arterial thrombotic events
Christopher J Boos, Gregory Y H Lip
The American Journal of Cardiology
|
September 26, 2006
C-reactive protein and lone atrial fibrillation: potential confounders
Christopher J Boos, Gregory Y H Lip
Page
of 26
Search research articles
Search
Showing results (31-40 of 257) with videos related to
Sort By:
Page
of 26
Expert Review of Cardiovascular Therapy
|
August 4, 2005
Ximelagatran for stroke prevention in atrial fibrillation
Christopher J Boos, Gregory Y H Lip
Klinische Padiatrie
|
July 1, 1996
[HIT-GBM: multicenter study of treatment of children with malignant glioma]
J E Wolff, J Boos, J Kühl
Journal of the American College of Cardiology
|
February 21, 2006
Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers
Christopher J Boos, Gregory Y H Lip
Heart (British Cardiac Society)
|
September 15, 2005
Antithrombotic treatment in atrial fibrillation
G Y H Lip, C J Boos
Journal of Human Hypertension
|
May 21, 2005
Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension?
C J Boos, G Y H Lip
American Journal of Hypertension
|
May 2, 2006
Urotensin and cardiovascular risk among patients with end-stage renal disease: fact or fiction?
Christopher J Boos, Gregory Y H Lip
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
July 15, 2004
Multiple tumors associated with late-onset congenital adrenal hyperplasia due to aberrant splicing of adrenal 21-hydroxylase gene
Chris J Boos, Gill Rumsby, Glenn Matfin
Expert Opinion on Investigational Drugs
|
November 30, 2004
Novel therapies for the prevention of stroke
Christopher J Boos, Gregory Y H Lip
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 21, 2006
Assessment of hemostatic risk factors in predicting arterial thrombotic events
Christopher J Boos, Gregory Y H Lip
The American Journal of Cardiology
|
September 26, 2006
C-reactive protein and lone atrial fibrillation: potential confounders
Christopher J Boos, Gregory Y H Lip
Page
of 26